Leonor Rodrigues-Ribeiro
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cleavage of the TrkB-FL receptor during epileptogenesis: insights from a kainic acid-induced model of epilepsy and human samples.
Journal: Pharmacological research
Published: December 20, 2024
A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 13, 2024
Selective modulation of epileptic tissue by an adenosine A3 receptor-activating drug.
Journal: British journal of pharmacology
Published: March 27, 2024
A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 20, 2024
Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-β-Induced Alzheimer's Disease Model.
Journal: Journal of Alzheimer's disease : JAD
Published: June 21, 2021
Challenges of BDNF-based therapies: From common to rare diseases.
Journal: Pharmacological research
Published: September 15, 2020
Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy.
Journal: International journal of molecular sciences
Published: September 10, 2020
NLRP3 inflammasome as a potential target to reduce epileptic-like activity: PS188.
Journal: Porto biomedical journal
Published: September 01, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026